Human trial
Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance.
Humans under GH-receptor blockade
Reported findings. Acute metabolic observations
Nonresponse. Does not establish ordinary wellness outcomes
Harms. Insulin-resistance finding requires receptor-blockade context
Limits. No transfer to other routes/formulations/indications; clinician review pending.
Preparation: GHRP-6 with pegvisomant Route: Unknown in abstract
Read original source ↗Editorial review 2026-10-09. Clinician review pending.